Glaxo Boasts Its Cervarix Vaccine Protects Against Five Most Common HPV Strains
This article was originally published in The Pink Sheet Daily
Executive Summary
The drug maker hopes the data will reverse a long-delayed approval in the U.S., where Merck's Gardasil has a commanding lead.